A cardiac prevention and rehabilitation programme for all patients at first presentation with coronary artery disease

Heart

Volumn 85, Issue 5, 2001, Pages 533-538

  Fox, K F ^a   Wood, D A ^a   Wright, M ^a   Sutcliffe, S J ^a   Nuttall, M ^b   Arora, B ^b   Dawson, E ^b   Devane, P ^b   Stock, K ^b   Brown, K ^b  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^b Bromley Hospitals NHS Trust   (United Kingdom)

Author keywords

Coronary artery disease; Preventive policy; Rehabilitation

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

ADULT; AGED; ARTICLE; CORONARY ARTERY DISEASE; FEMALE; HEALTH PROGRAM; HEART MUSCLE REVASCULARIZATION; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REHABILITATION MEDICINE; RISK FACTOR;

EID: 0034757351     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.85.5.533     Document Type: Article

References (23)

1. The clinical incidence of fatal and non-fatal coronary heart disease in the population
2. Effect of coronary artery bypass graft surgery on survival: Overview of 10 year results from randomized trials by the coronary artery bypass graft surgery trialists collaboration
3. Incidence, clinical characteristics and short-term prognosis of angina pectoris
4. An analysis of the effectiveness of interventions intended to help people stop smoking
5. Collaborative overview of randomised trials of antiplatelet therapy. 1. Prevention of death, myocardial infarction and stroke by prolonged antiplatelet therapy in various categories of patients
6. Beta blockade after myocardial infarction: Systematic review and meta regression analysis
7. A randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian simvastatin survival study (4S)
8. The effect of pravastatin on coronary events after myocardial infarction in patients with average lipid levels
9. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
10. Effects of ramipril on morbidity and mortality of survivors of acute myocardial infarction with clinical evidence of heart failure
11. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high risk patients
12. A British Cardiac Society survey of the potential for the secondary prevention of coronary disease: ASPIRE (action on secondary prevention through intervention to reduce events). Principal results
13. Why patients do not attend cardiac rehabilitation: Role of intentions and illness beliefs
14. Joint British recommendations on prevention of coronary heart disease in clinical practice
15. Toward a comprehensive model of change
16. Concordance for coronary risk factors among spouses
17. Changes in coronary risk and risk factor levels in couples following lifestyle intervention: The British family heart study
18. Dietary change after smoking cessation: A prospective study
19. Randomised controlled trial of follow up care in general practice of patients with myocardial infarction and angina: Final results of the Southampton heart integrated care project (SHIP)
20. Effect of postal prompts to patients and general practitioners on the quality of primary care after a coronary event (POST): Randomised control trial
21. Randomised controlled trial of health promotion in general practice for patients at high cardiovascular risk
22. Secondary prevention in coronary heart disease: A randomised trial of nurse led clinics in primary care